Assessment of Treatment Outcomes of Interstitial Cystitis with Sodium Hyaluronate by The O’leary-Sant Interstitial Cystitis Symptom Index (ICSI) and Interstitial Cystitis Problem Index (ICPI))

Fuad Hariyanto, M Surya Negara

Abstract


Objective: To assess the treatment outcome of interstitial cystitis with sodium hyaluronate (cystistat) installation by O’Leary-Sant interstitial cystitis symptom index (ICSI) and interstitial cystitis problem index (ICPI).

Material and methods: From January 2019 to October 2020, 11 patients diagnosed with interstitial cystitis were treated with sodium hyaluronate (cystistat) installation. Each patient was assessed using the O’Leary-Sant interstitial cystitis symptom index (ICSI) and interstitial cystitis problem index (ICPI) before and after therapy.

Results: The number of interstitial cystitis patients who completed the installation program in this study was 11 patients. In the assessment of interstitial cystitis symptom index (ICSI), there was a significant clinical improvement in each of the symptoms, which are urgency, frequency, nocturia, and bladder pain, with statistical test results obtained p-value (0.002, 0.003, 0.003, and 0.003) consecutively. In the interstitial cystitis problem index (ICPI) study, clinical improvements were obtained from each symptom in the form of urgency, frequency, nocturia, and bladder pain with statistical test results obtained p-value (0.002, 0.003, 0.003, and 0.003) consecutively.

Conclusion: In all interstitial cystitis patients who were treated with sodium hyaluronate installation in this study, there was a significant difference in the values of O’Leary-Sant interstitial cystitis symptom index (ICSI) and interstitial cystitis problem index (ICPI) before and after therapy. This shows that sodium hyaluronate (cystistat) installation therapy is very effective for interstitial cystitis patients.


Keywords


interstitial cystitis, sodium hyaluronate, O’Leary-Sant interstitial cystitis symptom index (ICSI) and interstitial cystitis problem index (ICPI)

Full Text:

PDF

References


Scott A. MacDiarmid, MD, Peter K. Sand, MD, Diagnosis of Interstitial Cystitis/ Painful Bladder Syndrome in Patients with Overactive Bladder Symptoms: REVIEWS IN UROLOGY. VOL. 9 NO. 1; 2007.

Ikatan Ahli Urologi Indonesia (IAUI) Perkumpulan Kontinensia Indonesia (PERKINA): Panduan Tata Laksana Sindrom Nyeri Kandung Kemih; 2019.

Van de Merwe JP, Nordling J, Bouchelouche P, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008 Jan;53(1):60-7.

Temml, C., et al. Prevalence and correlates for interstitial cystitis symptoms in women participating in a health screening project. Eur Urol. 2007;51: 803.

Oravisto, K.J. Epidemiology of interstitial cystitis. Ann Chir Gynaecol Fenn. 1975; 64: 75.

Warren JW, Wesselmann U, Morozov V, et al. Numbers and types of nonbladder syndromes as risk factors for interstitial cystitis/painful bladder syndrome. 2011 Feb;77(2):313-9.

Warren JW, Brown V, Jacobs S, et al. Urinary Tract Infection and Inflammation at Onset of Interstitial Cystitis/Painful bladder Syndrome. Urology. 2008 Jun;71(6):1085-90.

Parsons CL, Stein P, Zupkas P, et al. Defective Tamm-Horsfall protein in patients with interstitial cystitis. J Urol. 2007 Dec;178(6):2665-70.

Hanno P, Lin A, Nordling J, Nyberg L, van Ophoven A, Ueda T, et al. Bladder pain syndrome committee of the International consultation on incontinence. Neurourol Urodyn. 2010; 29:191e8.

Lai MC, Kuo YC, Kuo HC. Intravesical hyaluronic acid for interstitial cystitis/ painful bladder syndrome: a comparative randomized assessment of different regimens. Int J Urol. 2013; 20:203e7.

Pyo, J.S., et al. Systematic Review and Meta-Analysis of Intravesical Hyaluronic Acid and Hyaluronic Acid/Chondroitin Sulfate Instillation for Interstitial Cystitis/Painful Bladder.

M.-C. Huang et al. Assessment of treatment outcomes of interstitial cystitis with hydrodistention and bladder training by O'Leary-Sant Interstitial Cystitis Symptom and Problem Indices): Taiwanese Journal of Obstetrics & Gynecology 57. 2018; 718e721.

Engelar D., et al. EAU Guidelines on Chronic Pelvic Pain. European Urology Association; 2019.

Scarneciu, et al. Efficacy of instillation treatment with hyaluronic acid in relieving symptoms in patients with BPS/IC and uncomplicated recurrent urinary tract infections - Long-term results of a multicenter study: European Journal of Pharmaceutical Sciences 139. 2019; 10506.

M.-J. Hung et al. Hyaluronic acid improves pain symptoms more than bladder storage symptoms in women with interstitial cystitis Taiwanese Journal of Obstetrics & Gynecology 58. 2019; 417e422.

Raymon/Vasdev/Ferguson/Haskin/Davis/Hasan. The Clinical Effectiveness of Intravesical Sodium Hyaluronate (Cystistat®) in Patients with Interstitial Cystitis/Painful Bladder Syndrome and Recurrent Urinary Tract Infections: 2012. Department of Urology, Freeman Hospital, Newcastle upon Tyne, UK. Curr Urol. 2012; 6:93–98.

Barua, JM, Arance I, Angulo, JC, Riedl, A Systematic review and meta-analysis on the efficacy of intravesical therapy for bladder pain syndrome/interstitial cystitis: CR. In Urogynecol J. 2015; 10.1007/s00192-015-2890-7.




DOI: https://doi.org/10.15408/avicenna.v2i1.18827 Abstract - 0 PDF - 0

Refbacks

  • There are currently no refbacks.


Indexed By: